Mutational Analysis of BRCA1 and BRCA2 Genes in Breast Cancer Patients from Eastern Sicily

Abstract

Purpose Germline mutations of BRCA1 and BRCA2 are associated with a defined lifetime risk of breast (BC), ovarian (OC) and other cancers. Testing BRCA genes is pivotal to assess individual risk, but also to pursue preventive approaches in healthy carriers and tailored treatments in tumor patients. The prevalence of BRCA1 and BRCA2 alterations varies broadly across different geographic regions and, despite data about BRCA pathogenic variants among Sicilian families exist, studies specifically addressing eastern Sicily population are lacking. The aim of our study was to investigate the incidence and distribution of BRCA pathogenic germline alterations in a cohort of BC patients from eastern Sicily and to evaluate their associations with specific BC features. Patients and Methods Mutational status was assessed in a cohort of 389 BC patients, using next generation sequencing. The presence of alterations was correlated with tumor grading and proliferation index. Results Overall, 35 patients (9%) harbored a BRCA pathogenic variant, 17 (49%) in BRCA1 and 18 (51%) in BRCA2. BRCA1 alterations were prevalent among triple negative BC patients, whereas BRCA2 mutations were more common in subjects with luminal B BC. Tumor grading and proliferation index were both significantly higher among subjects with BRCA1 variants compared to non-carriers. Conclusion Our findings provide an overview about BRCA mutational status among BC patients from eastern Sicily and confirm the role of NGS analysis to identify hereditary BC patients. Overall, these data are consistent with previous evidences supporting BRCA screening to properly prevent and treat cancer among mutation carriers.

BRCA mutation status and pathological characterization of breast cancer in Zhoushan Islands, China

“…The BRCA1 / 2 gene mutation features of Zhoushan Island are thus likely different from Western populations, and even from those of other Asian countries. Compared with populations from other regions with geographical proximity to the sea, the BRCA1 / 2 mutations of patients with breast cancer in Zhoushan Islands were lower than those reported in Korea, 33 , 40 Japan, 34 , 41 and Sicily 42 , regardless of whether patients were unselected or had breast/ovarian cancer ( Chart 2 ).…”

A nomogram model combining ultrasound-based radiomics features and clinicopathological factors to identify germline BRCA1/2 mutation in invasive breast cancer patients

“…Another interesting finding is that Ki-67 level was firstly described as an independent predictor of BRCA1/2 mutation (OR 4.609, p = 0.015) in breast cancer patients in this study. Although Ki-67 was not mentioned in the NCCN criteria [ 12 ] and often neglected in BRCA1/2-related studies, higher Ki-67 levels in BRCA1/2-mutated breast cancer patients have been reported in multiple studies [ 29 , [44] , [45] , [46] ].…”

Navigating the Nexus: HIV and Breast Cancer—A Critical Review

“…The significance of traditional BC risk factors such as hormonal influences, genetics, and lifestyle factors [ 18 , 19 ] and their interaction with HIV-related immunological changes cannot be overstated. The interplay between these factors is complex and requires in-depth exploration.…”